lysophosphatidic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Birnberg, A; Chakrabarti, A; Choy, DF; Grimbaldeston, MA; Li, Q; Neighbors, M; Olsson, J; Rosenberger, CM; Sandoval, W; Tew, GW; Verschueren, E; Wong, W; Yang, X | 1 |
| Birnberg, A; Chakrabarti, A; Grimbaldeston, M; Li, Q; Neighbors, M; Rosenberger, C; Sandoval, W; Tew, GW; Verschueren, E; Wong, WR; Yang, X | 1 |
| Borges, VM; Bowler, RP; Fessler, MB; Henson, PM; Janssen, WJ; Kench, JA; McPhillips, KA; Morimoto, K; Vandivier, RW; Xiao, YQ | 1 |
1 trial(s) available for lysophosphatidic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Serum Lysophosphatidic Acid Measurement by Liquid Chromatography-Mass Spectrometry in COPD Patients.
Topics: Age Factors; Aged; Biomarkers; Blood Chemical Analysis; Body Mass Index; Case-Control Studies; Chromatography, Liquid; Cohort Studies; Female; Humans; Limit of Detection; Lysophospholipids; Male; Mass Spectrometry; Middle Aged; Pulmonary Disease, Chronic Obstructive; Reproducibility of Results; Vital Capacity; Workflow | 2021 |
2 other study(ies) available for lysophosphatidic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.
Topics: Aged; Biomarkers; Disease Progression; Female; Humans; Logistic Models; Lysophospholipids; Male; Middle Aged; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Severity of Illness Index | 2021 |
Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.
Topics: Animals; Apoptosis; CD36 Antigens; Cells, Cultured; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jurkat Cells; Lovastatin; Lung; Lysophospholipids; Macrophages; Macrophages, Alveolar; Membrane Proteins; Mice; Mice, Inbred ICR; Monocytes; Phagocytosis; Protein Prenylation; Pulmonary Disease, Chronic Obstructive; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein | 2006 |